Background and Purpose-We previously reported the infarct volumes in female spontaneously hypertensive rats (SHR) to be significantly smaller than those in male SHR. The purpose of the present study was to determine whether estrogen is responsible for the sex difference in ischemic vulnerability in SHR. Methods-In experiment 1, 1 week (short-term) or 4 weeks (long-term) after the ovariectomy (OVX), female SHR (5 months old) were randomly subjected to photothrombotic occlusion of the middle cerebral artery, and the infarct volumes were determined. In experiment 2, the rats were randomly assigned to 3 groups (ie, the sham-ovariectomized, ovariectomized, and estrogen replacement groups). In the replacement group, estradiol valerate (200 g/kg) was subcutaneously injected once a week after the OVX. Four weeks after the OVX or sham-OVX, all rats were subjected to middle cerebral artery occlusion. Changes in regional cerebral blood flow were determined by laser-Doppler flowmetry. Results-In experiment 1, the infarct volume produced 1 week after the OVX was not different from that of the sham-ovariectomized group. In contrast, the infarct volume produced 4 weeks after the OVX was significantly larger than that of the sham-ovariectomized group (82.4Ϯ11.6 versus 54.5Ϯ16.0 mm 3 , Pϭ0.0058). In experiment 2, estradiol replacement after the OVX was observed to attenuate the infarct volume compared with the ovariectomized group (55.6Ϯ18.8 versus 78.5Ϯ21.0 mm 3 , Pϭ0.0321). The degrees of regional cerebral blood flow reduction did not differ among the sham-ovariectomized, ovariectomized, and estrogen replacement groups. Conclusions-Chronic estrogen depletion was thus found to increase the infarct size, which was attenuated by estradiol replacement. These findings indicate that estrogen contributes to the sex difference in ischemic vulnerability and that endogenous estrogen also has a neuroprotective effect against ischemic brain damage. (Stroke. 2000;31:155-160.)
I n experimental stroke, female animals tend to show more tolerance to ischemic injury of the brain than males. [1] [2] [3] [4] [5] For example, female gerbils displayed a lower incidence of overt neurological signs and less neuronal loss after unilateral carotid occlusion. 3 We previously reported that the infarct size after middle cerebral artery (MCA) occlusion was significantly smaller in female spontaneously hypertensive rats (SHR) than in male SHR. 5 But it remains unclear whether the sex difference in infarct size is a consequence of lower blood pressure levels in female SHR or is due to a neuroprotective or anti-ischemic effect of the gonadal hormones (eg, estrogen).
Recent studies suggest that estrogen protects against ischemic injury in vivo. In a study of MCA occlusion, ovariectomy (OVX) resulted in an increased infarct size in female rats,
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comparable to that in male rats. 6 Administration of estrogen after MCA occlusion reduced mortality and infarct volumes. 7 Estrogen pretreatment reduced ischemic injury in OVX female rats 8 and showed a similar reduction in male rats. 9 In these studies, however, the effects of estrogen on regional cerebral blood flow (CBF) during ischemia are controversial. 3,6,8 -11 Estrogen has been shown to be a vasoactive steroid, [12] [13] [14] and Alkayed et al 6 demonstrated the intraischemic cortical flow in female rats to be higher than in males. In contrast, Dubal et al 8 showed that ischemic regional CBF did not differ between the estradiolpretreated and oil-pretreated control rats.
Hypertensive rats are relevant to stroke research and are widely used for studies of hypertension-related cerebrovas-cular complications. Thrombotic brain infarction is a major type of human stroke. Postmenopausal women are at risk for various cardiovascular events, including thrombotic stroke. [15] [16] [17] [18] We therefore investigated the effects of OVX and estrogen replacement in this thrombotic focal ischemia model of SHR. 19, 20 The purpose of the present study was to determine whether or not estrogen is responsible for the sex difference in ischemic vulnerability in SHR.
Materials and Methods
All procedures were done in accordance with the Animal Care Guidelines of Kyushu University.
Materials
Female SHR (5 months old, 190 to 230 g body weight) were maintained in the Kyushu University Animal Center under a 12:12-hour light-dark cycle with unrestricted access to food and water. The rats were bilaterally ovariectomized or sham-ovariectomized under amobarbital anesthesia (100 mg/kg IP). In experiment 1, 1 week (short-term) or 4 weeks (long-term) after the OVX or sham-OVX, the rats were subjected to MCA occlusion. In experiment 2, the rats were randomly assigned to 3 groups, as follows. The first group of rats received sham-OVX, and the second and third groups were ovariectomized. The rats in the third group were subcutaneously injected with a depot preparation of estradiol valerate (200 g/kg; Mochida Pharmaceutical Co) suspended in sesame oil once a week for 3 weeks commencing 1 week after OVX (estrogen replacement group, nϭ8). The rats in the first group (sham-OVX group, nϭ8) and second group (OVX group, nϭ8) were injected with the same amount of sesame oil as a vehicle once a week. All rats were subjected to MCA occlusion 4 weeks after either OVX or sham-OVX.
Surgical Procedures
The rats were anesthetized with halothane (4% for induction; 1.5% during the surgical preparation, with a face mask; 0.75% after intubation; and 0.5% for maintenance) in a mixture of 70% nitrous oxide and 30% oxygen. The right femoral artery and vein were cannulated with PE 50 tubing. The rats were endotracheally intubated with PE 205 tubing. Pancuronium bromide (an initial dose of 0.3 mg followed by 0.1 mg every 30 minutes) was injected intravenously, and the rats were mechanically ventilated. The mean arterial blood pressure was monitored continuously, and physiological variables were determined before and after distal MCA occlusion. The rectal and head temperatures were maintained at 37°C and 36°C, respectively, by means of a warming lamp.
The rats were mounted on a stereotaxic head holder in a prone position, and a 2-cm incision was made vertically midway between the right orbit and the right external auditory canal. The temporalis muscle was separated and retracted while a burr hole 3 mm in diameter was made 1 mm rostral to the anterior junction of the zygoma and squamosal bones (under an operation microscope), thus revealing the distal segment of the MCA above the rhinal fissure. The dura was left intact.
Photothrombotic Distal MCA Occlusion
A krypton laser operating at 568 nm (Innova 301, Coherent Inc) was used to irradiate the distal MCA at a power of 20 mW. The laser beam was focused with a cylindrical lens with a 30-cm focal length (CKX 300, Newport Corp) and positioned with a mirror onto the distal MCA. The photosensitizing dye rose bengal (15 mg/mL in 0.9% saline; Wako Pure Chemical Industries Ltd) was administered intravenously at a dose of 20 mg/kg over 90 seconds simultaneously with 4 minutes of laser irradiation. One hour after distal MCA occlusion, the head wound was closed, and the catheters were removed. The rats were carefully weaned from the respirator and returned to the home cage after regaining the ability to breath independently.
Measurement of the Regional CBF
In experiment 2, the regional CBFs were determined by laser-Doppler flowmetry 10, 30, and 60 minutes after MCA occlusion. Through a craniotomy, a laser-Doppler flowmetry probe was laterally scanned, and CBF was measured at 5 points (1 mm posterior and 2.0, 2.5, 3.0, 3.5, and 4.0 mm lateral to the bregma). 21 Because visible light interferes with laser-Doppler flowmetry, the heating lamp was temporarily turned off during measurements of CBF. Changes in CBF were expressed as a percentage of the average of 3 baseline values. 
Quantification of the Infarct Volume
After 3 days, the rat was decapitated, and the brain was rapidly removed. The entire brain was cooled in ice-cold saline for 10 minutes and cut into 2-mm-thick coronal sections in a cutting block; the brain slices were then immersed in 2% 2,3,5-triphenyltetrazolium chloride (Wako Pure Chemical Industries Ltd.) at 37°C for 30 minutes in the dark. The posterior surface of each section was photographed, and the infarct areas, indicated by a lack of staining, were determined with NIH Image software (version 1.56). The infarct volume of each rat was calculated according to the trapezoidal rule. 22 
Plasma Estradiol Assays
In a separate experiment, 1 week after the last of 3 injections, plasma 17␤-estradiol samples were obtained from the femoral artery and centrifuged and then were frozen until the time of assay. Samples (0.5 mL) were analyzed for estradiol by a radioimmunoassay after ether extraction.
Statistical Analysis
The values were expressed as the meanϮSD. Differences in physiological variables, infarct volume, and changes in CBF were analyzed with ANOVA followed by Fisher's protected least significant difference test. The levels of significance were set at PϽ0.05.
Results

Experiment 1
There were no significant differences in mean blood pressure, head temperature, rectal temperature, blood gases, hematocrit, and blood glucose among the groups in experiment 1 ( Table 1) . These physiological variables were not significantly different at 5, 30, and 60 minutes after MCA occlusion (data not shown). Body weight in the rats 4 weeks after OVX was higher than that in the other 3 groups. The infarct volume produced 1 week after OVX was 46.8Ϯ10.5 mm 3 , which was not different from the 61.1Ϯ16.2 mm 3 observed in the sham-ovariectomized group. In contrast, the infarct volume produced 4 weeks after OVX was 82.4Ϯ11.6 mm 3 , which was significantly larger than the 54.5Ϯ16.0 mm 3 in the sham-ovariectomized group (Pϭ0.0058) ( Table 2) . Table 3 demonstrates the physiological variables in experiment 2, which showed no significant differences among the groups. OVX increased the body weight gain to the same degree as experiment 1, and estrogen replacement reversed this effect (Figure 1 ). There are no significant correlations between body weight and infarct volume either in the sham-OVX (Pearson's correlation coefficient, rϭ0.147, nϭ18) or in the OVX group (rϭ0.030, nϭ13). Figure 2 demonstrates infarct volumes in the sham-OVX, OVX, and estrogen replacement groups. The OVX group showed a larger infarction (78.5Ϯ21.0 mm 3 ) than the sham-OVX group (49.9Ϯ19.8 mm 3 ), and the difference was significant (Pϭ0.0091). Estrogen replacement after OVX attenuated the infarct volume (55.6Ϯ18.8 mm 3 ) compared with the OVX group (Pϭ0.0321). The average size of the cortical infarction in each group is presented in Figure 3 . Figure 4 demonstrates the changes in the regional CBF measured by laser-Doppler flowmetry 30 minutes after MCA occlusion. The degree of regional CBF reductions did not differ among the sham-OVX, OVX, and estrogen replacement groups at any regions (2.0 mm to 4.0 mm from midline).
Experiment 2
No differences were observed among the 3 groups 10 and 60 minutes after MCA occlusion (data not shown).
The plasma estradiol levels determined 1 week after the last injection were 8.1Ϯ6.9, 3.8Ϯ1.0, and 31.1Ϯ19.4 pg/mL in the sham-OVX, OVX, and estrogen replacement groups, respectively (nϭ5). The estradiol level in the estrogen replacement group remained within the physiological level, but it was slightly higher than the basal circulating estradiol level in female rats during the estrous cycle and was close to the proestrous estradiol level. 23, 24 
Discussion
In this study, we demonstrated that OVX increased the infarct size after photothrombotic focal ischemia by 50%, whereas estrogen replacement reversed this effect. This finding suggests that estrogen may be responsible for the observed sex-linked differences in susceptibility to cerebral ischemia in experimental stroke. Because OVX rats had decreased plasma levels of gonadal hormones at 24 hours after OVX, 24, 25 the different infarct size between the short-term and long-term OVX groups might have resulted from the different durations of gonadal hormone depletion. The effects of estrogen on regional CBF reductions during ischemia remain controversial in previous studies. 3,6,8 -11 The degree of regional CBF reductions did not differ among the sham-OVX, OVX, and estrogen replacement groups in our present study. Because OVX and estradiol pretreatment were shown not to alter the baseline CBF, 11, 26 our results thus suggested that blood flow-independent neuroprotective mechanisms are responsible for the differences in infarct size in our model of photothrombotic MCA occlusion.
Several possible mechanisms have been proposed to underlie the neuroprotective effects of estrogen. Previous studies demonstrated that glutamate toxicity was attenuated in cultured neurons pretreated with estrogen, suggesting that estrogen possesses antioxidant activities 27 or that the neuroprotective action is mediated through classic estrogen receptors. 28 Estrogen was shown to protect against N-methyl-Daspartate (NMDA)-induced neuronal cell death, thus directly inhibiting the NMDA receptor. 29 These findings suggest that one of the mechanisms by which estrogen exerts its neuroprotective effects is by attenuating the glutamate excitotoxicity in ischemic injury. Recently, Garcia-Segura et al 30 reported that Bcl-2-immunoreactive neurons were decreased by OVX and also showed a dose-dependent increase after estradiol administration to OVX rats. Because the apoptotic process may be a good target for therapeutic drugs aimed at limiting stroke damage, [31] [32] [33] [34] it may be important to investigate the effects of estrogen on the apoptotic process in cerebral ischemia.
The present study produced infarction by photothrombotic MCA occlusion, in which prominent platelet aggregation results in vascular occlusion. 19, 20 Other studies, but not all, have demonstrated that estrogen inhibits platelet aggregation. 35, 36 The possible beneficial action of estrogen to suppress harmful platelet activation in ischemia should be addressed in future studies.
We injected the rats with 200 g/kg of estradiol valerate once a week, and the plasma estradiol level, which was measured 1 week after the last injection, was 31.1Ϯ19.4 pg/mL, which was close to the physiological proestrous estradiol level. 23, 24 Both physiological high and physiological low doses (10 and 60 pg/mL of plasma estradiol concentration, respectively) were equally effective at reducing the size of ischemic injury. 8 Therefore, the relatively lower dose of estradiol valerate used in the present study was considered to be adequate to analyze the neuroprotective role of estrogen against brain ischemia. In addition, the neuroprotective effects of progesterone still cannot be ruled out, because the administration of progesterone to male rats or female cats reduced the degree of ischemic damage. 37, 38 In summary, we demonstrated here that chronic estrogen depletion increased the infarct size, which was thereafter attenuated by estradiol replacement. These findings indicate that estrogen contributes to the sex-linked difference in ischemic vulnerability, while endogenous estrogen also has a neuroprotective effect against ischemic damage.
